Polysomy of Chromosome 17 in Breast Cancer

Need multiple seats for your university or lab? Get a quote
The page below is a sample from the LabCE course HER2 Testing in Breast Cancer. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about HER2 Testing in Breast Cancer (online CE course)
Polysomy of Chromosome 17 in Breast Cancer

Polysomy 17 is defined as having more than 2 copies of the chromosome 17 centromere (green) signal. Polysomy 17 is observed in approximately 8% of all specimens, mostly among cases with 4-6 HER2 gene copies. Polysomy 17 should be noted if found. However, the significance of this finding is unknown.
The diagram illustrates polysomy of chromosome 17 (tetraploid in this instance) and would result in 4 copies of HER2/neu and may cause overexpression of protein without actual gene amplification. There would not be an increase in the ratio of HER2/neu to chromosome 17.